Platform Therapeutics
Andover, US · Founded 2022
Find your way into Platform Therapeutics
Sign up to see every warm intro you have to Platform Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Platform Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
PTX is a biotech company developing therapeutic solutions to mitigate adverse side effects associated with cancer chemotherapy and other medical treatments. The company focuses on improving patient quality of life during medical therapies through drug development.
Founders & leadership
JW
JAMES WILKIEExecutive
Board
LC
LAKHMIR CHAWLABoard director
Reported raises · per SEC filings
Form D private placements$1.8M disclosed across 1 round · 2026
▶$1.8MraisedAug 2026 · 1 investors · BiotechnologyRule 506(b)
▶$1.8MraisedAug 2026 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- JAMES WILKIEExecutive Officer, Director
- LAKHMIR CHAWLADirector
- Offering amount
- $4M
- Amount sold
- $1.8M
- First sale
- Aug 2026
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does Platform Therapeutics do?
- PTX is a biotech company developing therapeutic solutions to mitigate adverse side effects associated with cancer chemotherapy and other medical treatments. The company focuses on improving patient quality of life during medical therapies through drug development.
- How much funding has Platform Therapeutics raised?
- Platform Therapeutics has disclosed $1.8M raised across 1 round.
- Where is Platform Therapeutics headquartered?
- Platform Therapeutics is headquartered in Andover, US.